Literature DB >> 3884419

Production of insulin resistance by hyperinsulinaemia in man.

R A Rizza, L J Mandarino, J Genest, B A Baker, J E Gerich.   

Abstract

It has been proposed that hyperinsulinaemia may cause or exacerbate insulin resistance. The present studies were undertaken to test this hypothesis in man. Glucose utilization, glucose production, and overall glucose metabolism at submaximally and maximally effective plasma insulin concentrations (approximately 80 and approximately 1700 mU/l), and monocyte and adipocyte insulin binding were measured in normal volunteers on two occasions: once after 40 h of hyperinsulinaemia (25-35 mU/l) produced by infusion of insulin and once after infusion of saline (75 mmol/l; plasma insulin approximately 10 mU/l). After 40 h of hyperinsulinaemia, glucose utilization and overall glucose metabolism at submaximally and maximally effective plasma insulin concentrations were both slightly, but significantly, reduced compared with values observed after the infusion of saline (p less than 0.05), whereas glucose production rates were unaffected. Monocyte and adipocyte binding were also unaffected. These results indicate that hyperinsulinaemia of the magnitude observed in insulin resistant states, such as obesity, can produce insulin resistance in man. Assuming that human insulin sensitive tissues possess spare insulin receptors and that monocyte and adipocyte insulin binding accurately reflect insulin binding in insulin-sensitive tissues, the decreased maximal responses to insulin and the lack of change in insulin binding suggest that this insulin resistance occurred at a post-binding site.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884419     DOI: 10.1007/bf00279918

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  33 in total

Review 1.  Receptors for insulin, NSILA-s, and growth hormone: applications to disease states in man.

Authors:  J Roth; C R Kahn; M A Lesniak; P Gorden; P De Meyts; K Megyesi; D M Neville; J R Gavin; A H Soll; P Freychet; I D Goldfine; R S Bar; J A Archer
Journal:  Recent Prog Horm Res       Date:  1975

2.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

3.  Insulin-induced alterations in insulin binding and insulin action in primary cultures of rat hepatocytes.

Authors:  J M Amatruda; H W Newmeyer; C L Chang
Journal:  Diabetes       Date:  1982-02       Impact factor: 9.461

4.  Enhanced glucose utilization during prolonged glucose clamp studies.

Authors:  L Doberne; M S Greenfield; B Schulz; G M Reaven
Journal:  Diabetes       Date:  1981-10       Impact factor: 9.461

5.  Stoichiometric binding and regulation of insulin receptors on human diploid fibroblasts using physiologic insulin levels.

Authors:  D M Mott; B V Howard; P H Bennett
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

6.  Increased insulin responsiveness in vivo and in vitro consequent to induced hyperinsulinemia in the rat.

Authors:  E R Trimble; G C Weir; A Gjinovci; F Assimacopoulos-Jeannet; R Benzi; A E Renold
Journal:  Diabetes       Date:  1984-05       Impact factor: 9.461

7.  Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.

Authors:  J R Gavin; J Roth; D M Neville; P de Meyts; D N Buell
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

8.  Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting.

Authors:  R S Bar; P Gorden; J Roth; C R Kahn; P De Meyts
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

9.  Insulin binding and glucose uptake differences in rodent skeletal muscles.

Authors:  A Bonen; M H Tan; W M Watson-Wright
Journal:  Diabetes       Date:  1981-08       Impact factor: 9.461

10.  Insulin receptor binding and receptor-mediated insulin degradation in human adipocytes.

Authors:  O Pedersen; E Hjøllund; H Beck-Nielsen; H O Lindskov; O Sonne; J Gliemann
Journal:  Diabetologia       Date:  1981-06       Impact factor: 10.122

View more
  69 in total

1.  Human growth hormone fragment (hGH44-91) produces insulin resistance and hyperinsulinemia but is less potent than 22 kDa hGH in the rat.

Authors:  M Hettiarachchi; A Watkinson; K C Leung; Y N Sinha; K K Ho; E W Kraegen
Journal:  Endocrine       Date:  1997-02       Impact factor: 3.633

2.  Defective glucose utilization in patients with functioning beta-cell tumors persists after tumor excision.

Authors:  G S McGee; M M Kulaylat; N N Abumrad
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

Review 3.  Recent developments in insulin delivery techniques. Current status and future potential.

Authors:  F P Kennedy
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

Review 4.  The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis.

Authors:  S C Bain; P M Dodson
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 5.  "Actin"g on GLUT4: membrane & cytoskeletal components of insulin action.

Authors:  Joseph T Brozinick; Bradley A Berkemeier; Jeffrey S Elmendorf
Journal:  Curr Diabetes Rev       Date:  2007-05

6.  Regulation of insulin secretion, glucokinase gene transcription and beta cell proliferation by adipocyte-derived Wnt signalling molecules.

Authors:  S Schinner; F Ulgen; C Papewalis; M Schott; A Woelk; A Vidal-Puig; W A Scherbaum
Journal:  Diabetologia       Date:  2007-11-10       Impact factor: 10.122

7.  Insulin resistance in a case of coexisting insulinoma and type 2 diabetes.

Authors:  G Grunberger
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

8.  Combined pancreas and kidney transplantation normalizes protein metabolism in insulin-dependent diabetic-uremic patients.

Authors:  L Luzi; A Battezzati; G Perseghin; E Bianchi; I Terruzzi; D Spotti; S Vergani; A Secchi; E La Rocca; G Ferrari
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 9.  Developmental programming of insulin resistance: are androgens the culprits?

Authors:  Muraly Puttabyatappa; Robert M Sargis; Vasantha Padmanabhan
Journal:  J Endocrinol       Date:  2020-06       Impact factor: 4.286

10.  Independent effects of obesity and insulin resistance on postprandial thermogenesis in men.

Authors:  K R Segal; J Albu; A Chun; A Edano; B Legaspi; F X Pi-Sunyer
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.